UT College of Pharmacy and Pharmaceutical Sciences News

Posts Tagged ‘BSPS’

New Investigator Award for Transdermal Research

Dr. Gabriella Baki

Dr. Gabriella Baki, Assistant Professor of Pharmaceutics and Director of the BSPS Cosmetic Science and Formulation Design program, received the $10,000 New Investigator Award from the American Association of Colleges of Pharmacy (AACP). The project title is “Enhancing the Delivery of Ibuprofen through the Skin Using In Silico Modeling.”


20 Years of the Bachelor of Science in Pharmaceutical Sciences Program

The College of Pharmacy and Pharmaceutical Sciences welcomed nearly 100 alumni and friends to a celebration of the 20th anniversary of the Bachelor of Science in Pharmaceutical Sciences program.  The Bachelor of Science in Pharmaceutical Sciences program at The University of Toledo offers the nation’s most comprehensive selection of undergraduate majors in the pharmaceutical sciences. The nationally ranked College of Pharmacy and Pharmaceutical Sciences is home to the nation’s only undergraduate program in Cosmetic Science and Formulation Design.

The celebratory program, at the Jacobs Interprofessional Immersive Simulation Center on the Health Science Campus, featured an alumni, student and faculty reception co-sponsored by the college’s Alumni Affiliate.  Following the reception, a talk by Dr. Frank Gerberick of Procter & Gamble was attended by over 65 individuals.  Dr. Gerberick spoke on “The Evolution of Test Methods for Predicting the Allergenic Potential of Chemicals and Proteins.”

Throughout 2017-2018, the college will celebrate this unique degree program by recognizing the accomplishments of our graduates.


State of the College 2016

Since 2013, Dean Early has delivered a State of the College address each fall at the Honors and Awards Convocation, a ceremony that recognizes student achievement and honors the donors and friends of the college. This year’s address focused on the return on investment seen by donors, new academic programs, the uniqueness of the college’s programs, and research.

Slideshow of presentation


Soligenix Appoints Alumna Karen Krumeich, BSP ’77, as Chief Financial Officer

PRINCETON, N.J., June 20, 2016 /PRNewswire/ — Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has appointed Karen Krumeich, as its Senior Vice President and Chief Financial Officer.  Ms. Krumeich has over 25 years of diverse experience in the financial and strategic management of emerging growth life science companies. She has a proven track record and expertise in corporate financial operations, equity financings, and business development, including partnerships, mergers and acquisitions.

Most recently, Ms. Krumeich served as a consultant providing finance, investor relations, and business development services to the Company and other healthcare companies. Previously, she worked as Vice President and Chief Financial Officer for several development-stage life science companies, including Cerecor, Inc. and Mela Sciences, Inc. where she was responsible for equity financings, corporate administrative functions, and investor relations. In addition to these positions, Ms. Krumeich was a healthcare consultant partner with Tatum, LLC, a national consulting firm, specializing in their life science practice. Prior to these positions, she held positions of increasing responsibility with several healthcare companies, including Bristol-Myers Squibb Company where she was Director of Health Systems and as Vice President of Finance for a national pharmacy provider. Ms. Krumeich began her career as a pharmacist and transitioned into finance after successfully completing the CPA exam.

Ms. Krumeich earned a BS in Pharmacy from the University of Toledo, Ohio and completed her post graduate work in accounting and finance at Cleveland State University while pursuing her career as a pharmacist.

“We are delighted to welcome Karen to our team, as we leverage her extensive financial expertise in leading our strategic corporate programs,” stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix.  “As we continue to execute our growth strategy, we are clearly building momentum and the talent we are attracting is an absolute reflection of our solid progress to date.  Karen’s unique experiences in both science and finance will be instrumental to us as we advance our multiple late-stage development programs.”

Mr. Joseph Warusz, who has served as Vice President, Finance and Acting Chief Financial Officer since February 2012, will be retiring from the Company effective June 30, 2016. On behalf of the Company and its Board of Directors, we would like to thank Joe for his many contributions during the past five years.

About Soligenix, Inc.

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Our BioTherapeutics business segment is developing SGX301 as a first-in-class photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma, proprietary formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders characterized by severe inflammation including pediatric Crohn’s disease (SGX203) and acute radiation enteritis (SGX201), and our novel innate defense regulator technology dusquetide (SGX942) for the treatment of oral mucositis.

Our Vaccines/BioDefense business segment includes active development programs for RiVax™, our ricin toxin vaccine candidate, OrbeShield®, our GI acute radiation syndrome therapeutic candidate and SGX943, our melioidosis therapeutic candidate. The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known as ThermoVax®.  Currently, this business segment is supported with up to $57 million in government grant and contract funding from the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).

For further information regarding Soligenix, Inc., please visit the Company’s website at www.soligenix.com.


Dean Early leads in Leadership Fellows program

Dean Early is currently serving as a Leadership Facilitator for the Academic Leadership Fellows Program (ALFP). He was selected by the American Association of Colleges of Pharmacy as a result of his highly successful leadership career and his experience and insight into leadership. The role of the Leadership Facilitator is to provide guidance and feedback on the Fellows’ individual personal and professional goals, as well as team projects.

The Academic Leadership Fellows Program is focused on the development of leaders in academic pharmacy and higher education. Fellows build relationships with colleagues from other institutions and from within the college and university. Each ALFP cohort has 30 Fellows, most of whom are mid-level faculty in pharmaceutical science, pharmacy practice, or Social and Administrative Sciences and have some type of current or projected leadership role in their college/school of pharmacy.

This year’s cohort of Fellows includes one UT faculty member, Dr. Amanda Bryant-Friedrich, an associate professor of medicinal chemistry and director of the newly established Shimadzu Laboratory for Pharmaceutical Research Excellence. A UT alumnus, Oscar Garza, is also a fellow this year. Dr. Garza earned a BS in Pharmaceutical Sciences at The University of Toledo and is now an assistant professor in the Department of Pharmaceutical Care and Health Systems at University of Minnesota College of Pharmacy.


Medicinal Chemistry grad student is inspired by personal medical journey

By Emily Esakov 

Emily Esakov’s parents with her sister, Ellen Esakov, at one month old

Emily’s parents, Sandra and David Esakov, with her sister, Ellen, at one month old

Photo Emily Esakov

Emily Esakov at one month old with her father, David

We were born at 26 weeks gestation on Dec. 11, 1989. I weighed 800grams (1 pound 12 ounces); my sister Ellen weighed 1 pound, 12 ounces, and my brother David weighed two pounds, two ounces. Our parents enrolled us in a clinical trial using a synthetic surfactant to help our lungs mature, which ultimately led to our survival.


I was anemic and had multiple lung diseases due to severe prematurity. I experienced episodes of lung collapse as well as a small hole in my heart (PFO) that closed with age (although I still have a murmur). I stayed in Akron Children’s Hospital neonatal intensive care unit for about three months and was discharged with my siblings on March 17, 1990.

Because we were premature, our development was delayed, not walking or speaking until around two years of age, but we had all caught up by the time we were in first grade.

Emily Esakov was the college's Student of the Month for September 2015.

Emily Esakov was the college’s Student of the Month for September 2015.

I grew up aware that our situation was unique, but it wasn’t until college that I truly understood the impact of the medical experiences my siblings and I had and how the odds had been stacked against us. Then, I really understood the miracle of us all being healthy adults today.

My pursuit of a Ph.D. in medicinal chemistry and a career in biomedical research is, in part, to help others fight against the odds stacked against them, just as the doctors and medical team did for my siblings and me.


Learning outside the Book

Jeremy Canfield photo

Jeremy Canfield, BSPS ’15, valedictorian of the 2015 B.S. in Pharmaceutical Sciences class, shares his advice on learning beyond the pages of the textbook.

Throughout my college career, I have learned many valuable lessons, both inside and outside of the classroom. I found it is extremely important to manage your time wisely and discipline yourself because everything you do in college is for your own benefit.

When I first started my journey here at Toledo, I didn’t know what to expect. I was excited, but very nervous to begin this new chapter in my life. It was hard starting over again and meeting new people, but I got through it just as you all did. From our PP1 year all the way to our P2 year, it may have been hard, but we made it. After everything, The College of Pharmacy Pharmaceutical Sciences has increased my passion for the pharmaceutical sciences and prepared me for a career. I gained a lot of hands on experience which I found to be more valuable than anything I could’ve read about in a book.

Over the past three years, one thing I found out about college is that in order to have the most enjoyable time, you have to get out of your comfort zone. That wasn’t easy for me, but with the help of some good friends, I started to try more new things. I realized college isn’t just about the courses you take and how you do on exams, it’s also about the people you meet and the experiences you have.

It’s hard to believe that it’s coming to an end already. But just as we began a new chapter when we started here at Toledo, today is the beginning of the next chapter in our lives. Whether we are continuing school or entering into the work force, we are all well prepared for what lies ahead.


Alison Wery, BSPS ’14, embarks on a career in cosmetic formulation

weryAlison Wery, BSPS ’14, may not realize it, but she is a pioneer. One of the first students to graduate with the nation’s only Cosmetic Science and Formulation Design bachelor’s degree, she has a unique set of skills and knowledge to apply in the cosmetic industry. Now a formulation scientist for ACT Solutions Corp., Wery’s internship experience at Earth Supplied Products, LLC. in Naples, Florida helped to establish her career path while she was still a student.

“I was supposed to be working under the lab manager,” Wery said, “but I ended up being their only chemist for an entire summer. This gave me the opportunity to do a little bit of everything. I made samples of raw materials like extracts and butters to send to companies. I also dealt with international and domestic shipment of samples, and I oversaw production of raw materials, technical service, organic certification, reformulation of all natural and organic lotions, creams, and scrubs, along with microreview and analysis, and stability analysis. It really influenced me to want to formulate and be in the lab.”

Wery’s work deals with contract manufacturing, which includes matching the formulations of products that are currently on the market with only the ingredient list as a guide. It’s like solving a mystery, one ingredient at a time.

“Trying to match a product with mislabeled or missing ingredient information is difficult, especially when the client doesn’t want any deviations from the ingredient listing. Also, certain ingredients don’t have to be listed on the label depending on their overall reason for use, solubilization for example. Ingredients also have different forms, and figuring out which form was used can be tricky; dimethicone, for example, has different grades – 5, 10, 100. 200, 350 – all of which give slightly different textures to a lotion or cream,” Wery explained.

The work is complex and challenging. Fortunately for Wery, her work is directly related to the coursework and lab experiences she had in the Cosmetic Science and Formulation Design program at UT.

“Knowing what each ingredient is – emollients, surfactants, and thickeners – along with the percentage to add and manufacturing procedure are all keys to what I do on a daily basis at my job,” she said.

What Wery most enjoys about her work is the success of the finished product.

“It is a lot like research in that you can do something a handful of times and it might not be quite right,” Wery said, “but once you tweak things, boom! You’ve got it!”

As her career progresses, Wery would like to move toward advanced formulation that includes revolutionary active ingredients, including transdermal drug delivery systems within the cosmetic field.

“A big issue in the cosmetic science industry right now is the delivery system for anti-aging ingredients and the goal of getting them into the deeper layers of skin for better results,” Wery said. “I would like to advance the research in this area.”

Even as Wery moves forward in her career, she appreciates what she learned in the College of Pharmacy and Pharmaceutical Sciences. Her class notes still come in handy, too. “I still look back at them sometimes for manufacturing procedures for certain products that we made in lab and even for information about the structure and pH of the skin, hair and nails,” she said.

Wery, who calls herself an “avid shopaholic,” is excited to have found a career path that blends her love of science and research with her desire to create personal care products like those she finds in her favorite high-end cosmetic boutiques. As the college continues to increase enrollment in the Cosmetic Science and Formulation Design major, more graduates like Wery will redefine the many ways we improve the human condition.


Presenting at a Cosmetic Science Symposium

phillisHillary Phillis, a cosmetic science and formulation design student who will graduate in May 2015, reports on her participation in a cosmetic science symposium. Part II will be featured in the March 2015 issue of Refill.

In September 2014, students in the Cosmetic Science and Formulation Design program traveled to the Future of Beauty Symposium hosted by the Michigan chapter of the Society of Cosmetic Chemists. The symposium was held in Grand Rapids, Mich., and Dean Early sponsored our lodging expenses. At the Frederik Meijer Gardens & Sculpture Park, we had the opportunity to network over hors d’oeuvres with cosmetic science industry professionals from businesses such as BASF, Dow Corning, Centerchem, Thor, Laurichem, Amway, and ShinEtsu.

The day of the symposium was filled with guest speakers who spoke on topics such as “The Future of Beauty: Trends & Innovations to watch,” “Regulatory Aspects of Non-Traditional Preservatives,” “Future Trends in Cosmetic & Personal Care Ingredients,” and “The Future of Testing and Ethnic Skin Care.” Four students, including myself, participated in the student poster competition, which included multiple poster sessions throughout the day. We introduced our posters and discussed multiple aspects of our research with members of the society.

I was honored to receive first place at the SCC MI Chapter fall symposium poster competition. I gave a short speech to the society upon receipt of my certificate and award money. I feel fortunate to have been given the opportunity to participate in this event and gain experience in the industry.


September 2014 Refill e-newsletter

The September 2014 issue of Refill, the e-newsletter of The University of Toledo College of Pharmacy and Pharmaceutical Sciences, is now available online.

In this issue:

  • The Full Spectrum: Diversity initiaves that improve the human condition
  • Sister to Sister: Science runs in the family for Yasmine and Samar Ayoub
  • Homecoming: Reasons to come home to UT
  • The Polished Professional: Mary Jo Borden helps students develop professional skills that are valued in the workplace
  • Leadership Lessons: Dr. Early shares advice on effective networking
  • Focused Ambition: Dual-degree programs and residencies offer exciting career paths
  • Legendary: Dean Early to be honored with community award
  • Calendar of Events